Cargando…
Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo
Autores principales: | Liu, Songyang, Zhang, Wei, Liu, Kai, Wang, Yingchao, Ji, Bai, Liu, Yahui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674705/ https://www.ncbi.nlm.nih.gov/pubmed/34841439 http://dx.doi.org/10.3892/or.2021.8235 |
Ejemplares similares
-
miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
por: Liu, Yahui, et al.
Publicado: (2022) -
miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2021) -
Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo
por: Pan, Yuan, et al.
Publicado: (2021) -
Additive effects of eukaryotic co-expression plasmid carrying GRIM-19 and LKB1 genes on breast cancer in vitro and in vivo
por: Zhang, Wei, et al.
Publicado: (2021) -
MicroRNA-744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12
por: Zhang, Wei, et al.
Publicado: (2022)